Advertisement

NMR Studies of Proteins Involved in Cell Adhesion Processes

  • Gerhard Wagner
  • Daniel F. Wyss
  • Johnathan S. Choi
  • Antonio R. N. Arulanandam
  • Ellis L. Reinherz
  • Andrzej Krezel
  • Robert A. Lazarus

Abstract

Many biological processes on the molecular level are associated with membrane-bound receptors or other integral membrane proteins. We have been working with proteins that are domains of receptors, or inhibit their function. The first topic are the T-cell surface glycoprotein receptor CD2 and its counter receptor CD58. The other topic is about antagonists of the integrin adhesion receptor glycoprotein IIbIIIa (GPIIbIIIa) which is found on platelet surfaces. Human CD2 is a glycoprotein, and the carbohydrate of its adhesion domain is crucial for adhesion function. The platelet receptor GPIIbIIIa, a Ca2+ dependent heterodimeric glycoprotein from the integrin family, binds fibrinogen and mediates the aggregation of platelets to form a blood clot. Natural protein antagonists of this receptor have primarily been found in the venum of various snakes, which have been termed disintegrins, and in the saliva of blood-sucking leeches. They contain an Arg-Gly-Asp (RGD) sequence in their active site. Due to the potent antiplatelet effect of these RGD proteins, the structures of their active sites have been of considerable interest for the design of antithromotic drugs.

Keywords

Cross Peak Adhesion Function Adhesion Domain Blood Clotting Process Charge Surface Area 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

References

  1. Adler, M, Lazarus, R, Dennis, M and Wagner G: Solution structure of kistrin a potent platelet aggregation inhibitor and integrin GPIIbllla antagonist, Science, 253, 445–448(1991).PubMedCrossRefGoogle Scholar
  2. Arulanandam, ARN, Kister, A, McGregor, MJ, Wyss, DF, Wagner, G and Reinherz, EL.: Interaction between CD2 and CD58 involves the major β-sheet surface of each of their respective adhesion domains. J. Exp. Med., 180, 1861–1871 (1994).PubMedCrossRefGoogle Scholar
  3. Arulanandam, ARN, Withka, JM, Wyss, DF, Wagner, G, Kister, A, Pallai, P, Recny, MA and Reinherz, EL.: The CD58 (LFA3) binding site is a localized and highly charged surface area on the AGFCC’C” face of the human CD2. Proc. Natl. Acad. Sci. USA. 90, 11613–11617 (1993).PubMedCrossRefGoogle Scholar
  4. Bang, NU and Clayman, MD: Antithrombotic agents from salivary glands of hematophagous animals. Trends Cardiovasc. Med. 2, 183–188 (1992).PubMedCrossRefGoogle Scholar
  5. Bodian, DL, Jones, EY, Harlos K, Stuart, DI and Davis, SJ. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure 2, 755–766 (1994).PubMedCrossRefGoogle Scholar
  6. Brady RL, Dodson EJ, Dodson GG, Lange G, Davis SJ, Williams AF and Barclay AN: Crystal Structure of Domains 3 and 4 of Rat CD4: Relation to the NH2-Terminal Domains. Science 260, 979–983(1993).Google Scholar
  7. Chothia, C, Novotny, Bruccoleri, R and Karplus, M: Domain association in immunoglobulin molecules. The packing of variable domains. J. Mol. Biol. 186, 651–663 (1985).PubMedCrossRefGoogle Scholar
  8. Clore, GM, Sukumaran, DK, Nilges, M, Zarbock, J and Gronenborn, A: The conformation of hirudin in solution: a study using nuclear magnetic resonance, distance geometry and restrained molecular dynamics. EMBO J. 6, 529–539 (1987).PubMedGoogle Scholar
  9. Davis SJ, Davis EA, Barclay AN, Daenke S, Bodian DL, Jones EY, Stuart DI, Butters TD, Dwek RA and van der Merwe PA. Ligand bindingby the immunoglobion superfamily recognition molecule CD2 is glycosylation-independent. J. Biol. Chem. 270, 369–375 (1995).PubMedCrossRefGoogle Scholar
  10. deVos, AM, Ultsch, M and Kossiakoff, AA: Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255, 306–312 (1992).CrossRefGoogle Scholar
  11. Driscoll, PC, Cyster, JG, Campbell, ID and Williams, AF: Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature, 353,762–765 (1991).PubMedCrossRefGoogle Scholar
  12. Haruyama, H and Wüthrich K: Conformation of recombinant desulfatohirudin in aqueous solution determined by nuclear magnetic resonance. Biochemistry 28,4312–4317 (1989).PubMedCrossRefGoogle Scholar
  13. Homans SW: Oligosaccharide conformations: Application of NMR and energy calculations. Progr. NMR Spectrosc. 22, 55–81 (1990).CrossRefGoogle Scholar
  14. Hynes, R O: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11–25CrossRefGoogle Scholar
  15. Jones, EY, Davis, SJ, Williams, AF, Harlos, K and Stuart, DI: Crystal structure at 2.8A resolution of a soluble form of the cell adhesion molecule CD2. Nature, 360, 232–239, (1992).PubMedCrossRefGoogle Scholar
  16. Karlsson GB, Butters TD, Dwek RA and Platt FM. Effects of the imino sugar N-butyldeoxynojirimycin on N-glycosylation of recombinant gpl20. J. Biol. Chem. 268, 570–576 (1993).PubMedGoogle Scholar
  17. Krezel, AM, Gerhard Wagner, G, Ulmer, JS, and Lazarus, RA: Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. Science 264, 1944–1947 (1994).PubMedCrossRefGoogle Scholar
  18. Lange G, Lewis SJ, Murshudov GN, Dodson GG, Moody PCE, Turkenburg JP, Barclay AN and Brady RL: Crystal Structure of an Extracellular Fragment of the Rat CD4 Receptor Containing Domains 3 and 4. Structure 2,469–481 (1994).PubMedCrossRefGoogle Scholar
  19. Lazarus, R A and McDowell, R S: Structural and functional aspects of RGD-containing protein antagonists of glycoprotein IIb-IIIa. Curr. Opin. Biotechnol. 4,438–445 (1993).PubMedCrossRefGoogle Scholar
  20. Leahy, DJ, Axel, R and Hendrickson, WA: Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6Å resolution. Cell 68,1145–1162 (1992).PubMedCrossRefGoogle Scholar
  21. Markwardt, F: The development of hirudin as an antithrombotic drug. Thromb. Res. 74, 1- 23 (1994).PubMedCrossRefGoogle Scholar
  22. Mazur, P, Henzel, WJ, Seymour, J L and Lazarus, R A: Ornatins: potent glycoprotein Ilbllla antagonists and platelet aggregation inhibitors from the leech Placobdella ornata.Eur. J. Biochem. 202, 1073–1082 (1991).PubMedCrossRefGoogle Scholar
  23. Niewiarowski, S, McLane MA, Kloczewiak, M, and Stewart, GJ: Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol. 31, 289–300 (1994).PubMedGoogle Scholar
  24. Nutt, E, Gasic, T, Rodkey, J, Gasic, GJ, Jacobs, JW and Friedman, PA: The amino acid sequence of antistasin. A potent inhibitor of Factor Xa reveals a repeated internal structure. J. Biol. Chem. 263, 10162–10167 (1988).PubMedGoogle Scholar
  25. Recny, MA, et al., & Reinherz, EL: N-Glycosylation is required for human CD2 immunoadhesion functions. J. Biol. Chem. 267, 22428–22434 (1992).PubMedGoogle Scholar
  26. Ribeiro, JMC: Role of saliva in blood-feeding arthropods. Ann. Rev. Entomol. 32, 463–478 (1987).CrossRefGoogle Scholar
  27. Ruoslahti, E and Pierschbacher, M D: New perspectives in cell adhesion: RGD and integrins. Science 238, 491–497 (1987).PubMedCrossRefGoogle Scholar
  28. Rydel, TJ, Ravichandran, KG, Tulinsky, A, Bode, W, Huber, R, Roitsch, Carolyn, Fenton II, JW: The structure of a complex of recombinant hirudin and human a-thrombin. Science 249, 277–280 (1990).PubMedCrossRefGoogle Scholar
  29. Ryu, SE, Kwong, PD, Truneh, A, Porter, TG, Arthos, J, Rosenberg M, Dai, X, Xuong, N, Axel, R, Sweet, RW and Hendrickson, WA: Crystal structure of an HIV- binding recombinant fragment of human CD4. Nature, 348,419–426 (1990).PubMedCrossRefGoogle Scholar
  30. Saudek, V, Atkinson, R A, Pelton J T: Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30,7369–7372 (1991)PubMedCrossRefGoogle Scholar
  31. Sawyer, RT: Leech Biology and Behaviour. Clarendon Press, Oxford (1986).Google Scholar
  32. Sawyer, RT: Thrombolytics and anticoagulants from leeches. Biotechnol. 9, 513–518 (1991).CrossRefGoogle Scholar
  33. Senn, H. and Klaus, W.: The nuclear magnetic resonance solution structure of flavoridin an antagonist of the platelet GPIIbIIIa receptor. J. Mol. Biol. 232, 907–925 (1993).PubMedCrossRefGoogle Scholar
  34. Seymour, JL, Henzel, WJ, Nevins, B, Stults, JT, and Lazarus, RA: Decorsin: A potent glycoprotein Ilb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J. Biol. Chem. 265, 10143–10147 (1990).PubMedGoogle Scholar
  35. Stocker, KF: Snake venom proteins affecting hemostasis and fibrinolysis. Medical Uses of Snake Venom Proteins (Stocker, K. F. ed) pp. 97–160, CRC Press, Boca Raton (1990).Google Scholar
  36. Szyperski, T, Giintert, P, Stone, SR and Wuthrich, K: Nuclear magnetic resonance solution structure of hirudin (1–51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain. J. Mol. Biol. 228, 1193- (1992).PubMedCrossRefGoogle Scholar
  37. Tuszynski, GP, Gasic, T B, Gasic, GJ: Isolation and characterization of antistasin. J. Biol. Chem. 262,9718–9723 (1987)PubMedGoogle Scholar
  38. Wang, J, Yan, Garrett, TPJ, Liu, J, Rodgers, DW, Garlick, RL, Tarr, GE, Husain, Y, Reinherz, EL and Harrison, SC: Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348,411–418 (1990).PubMedCrossRefGoogle Scholar
  39. Waxman, L, Smith, DE, Arcuri, KE, and Vlasuk, GP: Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation Factor Xa. Science 248, 593–596 (1990).PubMedCrossRefGoogle Scholar
  40. Withka, JM, Wyss, DF, Wagner, G, Arulanandam, ARN, Reinherz, EL and Recny, MA: Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. Structure, 1,69–81 (1993).PubMedCrossRefGoogle Scholar
  41. Wormald, MR, Wooten, EW, Bazzo, R, Edge, CJ, Feinstein, A, Rademacher, TW, and Dwek, RA: The conformational effects of N-glycosylation on the tailpiece from serum IgM, Eur. J. Biochem. 198, 131–139 (1991).PubMedCrossRefGoogle Scholar
  42. Wyss, DF, Choi JS, and Wagner G: Composition and sequence specific resonance assignments of te heterogeneous N-linked glycan in the 13.6 kDa adhesion domain of human CD2 as determined by NMR on the intact glycoprotein. Biochemistry, 34, 1622- 1634 (1995a).PubMedCrossRefGoogle Scholar
  43. Wyss, DF, Choi JS, Li, JL, Knoppers, MH, Willis, KJ, Arulanandam, ARN., Smolyar, A, Reinherz, EL andWagner G: Conformation and function of the N-linked Glycan in the Adhesion Domain of Human CD2. Science, in press (1995b).Google Scholar
  44. Wyss, DF, Withka, JM, Knoppers, MH, Sterne, KA, Recny, MA & Wagner, G: lH resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2. Biochemistry 32, 10995–11006 (1993).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Gerhard Wagner
    • 1
  • Daniel F. Wyss
    • 2
  • Johnathan S. Choi
    • 1
  • Antonio R. N. Arulanandam
    • 2
  • Ellis L. Reinherz
    • 3
  • Andrzej Krezel
    • 1
  • Robert A. Lazarus
    • 4
  1. 1.Department of Biological Chemistry and Molecular PharmacologyHarvard Medical SchoolBostonUSA
  2. 2.Procept, IncCambridgeUSA
  3. 3.Dana Farber Cancer InstituteBostonUSA
  4. 4.Department of Protein EngineeringSouth San FranciscoUSA

Personalised recommendations